ClinicalTrials.Veeva

Menu

Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Unknown
Phase 1

Conditions

Amphetamine-Related Disorders

Treatments

Drug: Bupropion

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00040040
NIDA-CTO-0010-1

Details and patient eligibility

About

The purpose of this study is to assess potential interactions between intravenous (IV) methamphetamine and oral bupropion.

Full description

This is a human laboratory clinical pharmacology study to assess potential interactions between IV methamphetamine challenge and treatment with oral sustained-release bupropion.

Sex

All

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Please contact site director for more details.

Exclusion criteria

Please contact site director for more details.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems